Active Ingredient(s): Roflumilast
FDA Approved: * July 29, 2022
Pharm Company: * ARCUTIS
Category: Lungs (Pulmonary)

Roflumilast, sold under the trade name Daxas among others, is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD).[6][7][8][9] In June 2010, it was approved in the European Union for severe COPD assoc... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zoryve 3 mg/g Topical Cream
NDC: 80610-130
Arcutis Biotherapeutics, Inc.
Zoryve 3 mg/g Topical Aerosol, Foam
NDC: 80610-430
Arcutis Biotherapeutics, Inc.

Related Brands

Drugs with the same active ingredients